Successful treatment of allergic bronchopulmonary aspergillosis with posaconazole in a child with cystic fibrosis: Case report and review of the literature

Allergic bronchopulmonary aspergillosis (ABPA) is recognized as a rare, progressive, allergic disorder in patients with cystic fibrosis (CF) and asthma. Treatment of ABPA mainly includes systemic corticosteroids (CSs) and antifungal agents. Here, we report posaconazole treatment in a 9-year-old male...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakut, Nurhayat, Kadayifci, Eda Kepenekli, Eralp, Ela Erdem, Gokdemir, Yasemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065555/
https://www.ncbi.nlm.nih.gov/pubmed/32108603
http://dx.doi.org/10.4103/lungindia.lungindia_288_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065555/
https://www.ncbi.nlm.nih.gov/pubmed/32108603
http://dx.doi.org/10.4103/lungindia.lungindia_288_19

Ejemplares similares